Manufacturer
Incyte
Pharmaceutical manufacturer based in United States
United States
- Products listed
- 20
- Molecules
- 5
- Therapy areas
- 1
Incyte is a pharmaceutical manufacturer based in United States. MedsAcross lists 20 of its products across 5 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- United States
- Indian manufacturer
- No
- Also listed as
- Incyte Corporation
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Incyte products through licensed channels, with the documents your regulator needs.
Oncology
16 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Jakafi 10 mg tabletOral | Ruxolitinib | US FDA | Available on request |
| Jakafi 15 mg tabletOral | Ruxolitinib | US FDA | Available on request |
| Jakafi 20 mg tabletOral | Ruxolitinib | US FDA | Available on request |
| Jakafi 25 mg tabletOral | Ruxolitinib | US FDA | Available on request |
| Jakafi 5 mg tabletOral | Ruxolitinib | US FDA | Available on request |
| Jakafi XR 11 mg extended-release tabletOral | Ruxolitinib | US FDA | Available on request |
| Jakafi XR 22 mg extended-release tabletOral | Ruxolitinib | US FDA | Available on request |
| Jakafi XR 33 mg extended-release tabletOral | Ruxolitinib | US FDA | Available on request |
| Jakafi XR 44 mg extended-release tabletOral | Ruxolitinib | US FDA | Available on request |
| Jakafi XR 55 mg extended-release tabletOral | Ruxolitinib | US FDA | Available on request |
| Monjuvi 200 mg/5 mL powder for injectionIntravenous Cold chain | Tafasitamab | US FDA | Available on request |
| Opzelura 1.5% creamTopical | Ruxolitinib | US FDA | Available on request |
| Pemazyre 13.5 mg tabletOral | Pemigatinib | US FDA | Available on request |
| Pemazyre 4.5 mg tabletOral | Pemigatinib | US FDA | Available on request |
| Pemazyre 9 mg tabletOral | Pemigatinib | US FDA | Available on request |
| Zynyz 500 mg/20 mL injectionIntravenous Cold chain | Retifanlimab | US FDA | Available on request |
Other products
4 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Niktimvo 22 mg/0.44 mL injectionIntravenous Cold chain | Axatilimab | US FDA | Available on request |
| Niktimvo 22 mg/2.2 mL injectionIntravenous Cold chain | Axatilimab | US FDA | Available on request |
| Niktimvo 9 mg/0.18 mL injectionIntravenous Cold chain | Axatilimab | US FDA | Available on request |
| Niktimvo 9 mg/0.9 mL injectionIntravenous Cold chain | Axatilimab | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Incyte
Send a request for any of these products. We confirm the licensed source, documents and lead time.